Publication | Closed Access
LINC00460 promotes pancreatic cancer progression by sponging miR‐491‐5p
16
Citations
43
References
2021
Year
This research showed that LINC00460 is overexpressed in PDAC and correlates with adverse clinical outcomes. Additionally, LINC00460 promotes the aggressiveness of PDAC by targeting miR-491-5p. Thus, LINC00460 may serve as diagnostic biomarker of PDAC and a new target for PDAC therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1